The most recent filing that T.D.
Asset Management INC, made with the Securities and Exchange Commission (SEC), reveals that during the third quarter of 2018, the company increased its position in shares of Alignment Healthcare, INC (NASDAQ: ALHC).
The corporation increased its ownership stake in the business during the quarter by purchasing an additional 59,484 shares of the company, bringing the total number of shares it owns in the enterprise to 231,822.
T.D.
Asset Management INC held 0.12% of Alignment Healthcare’s shares at the end of the most recent quarter.
The total value of these shares was $2,817,000 at the end of the quarter.
Several well-known investors have recently made modifications to the number of shares of the company’s stock they own.
During the third quarter, Robeco Institutional Asset Management B.V.
Paid approximately 32 thousand dollars to acquire a new stake in Alignment Healthcare.
During the second quarter, Nisa Investment Advisors LLC completed a 26.8 percentage point increase in the amount of Alignment Healthcare stock held in its portfolio. Nisa Investment Advisors LLC now has a total of 3,803 shares of the company’s stock, currently valued at $43,000, after purchasing an additional 803 shares during the period in question. U.S.
Bancorp DE increased the proportion of Alignment Healthcare stock owned by 15.8% during the second quarter of the fiscal year.
During the allotted period, U.S.
Bancorp DE made an additional purchase of 914 shares, bringing their total number of purchases to 6,704.
The total value of these purchases was $76,000.
The value of Quantbot Technologies L.P.’s holdings in Alignment Healthcare increased by 220.8% during the first three months of 2018.
After purchasing an additional 7,727 shares during the period, Quantbot Technologies L.P. now has 11,227 shares of the company’s stock, which are worth a combined total of $126,000. Finally, during the second quarter, the Teacher Retirement System of Texas paid approximately one hundred fifty thousand dollars to acquire a new interest in Alignment Healthcare.
This transaction took place during the quarter.
At present, 83.49% of the company’s shares are owned by hedge funds and other institutional investors.
Raymond James downgraded Alignment Healthcare from an “outperform” rating to a “market perform” rating in a research report published on November 21st. Nine analysts have given a buy recommendation for the stock, while only two have given a hold recommendation for the stock.
According to information made available by Bloomberg, the company’s stock is given a “Moderate Buy” recommendation by the market as a whole, and the price target has been established at $18.22.
ALHC shares were first offered for sale on Tuesday for $11.15.
The company’s market capitalization is currently valued at $2.09 billion, its price-to-earnings ratio is currently sitting at -14.29, and its beta is currently at 1.81.
The debt-to-equity ratio was calculated to be 0.59; the quick ratio was calculated to be 2.03; the current ratio was also calculated to be 2.03, and so on.
Leave a comment